Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a26ce837cb8a227c

Jump to content

// Workers AI · dad joke modeWho's Simone Courvoisier? Swiss to meet you.

From Wikipedia, the free encyclopedia

Simone Courvoisier was a French experimental pharmacologist who, while the head of pharmacology at Rhône-Poulenc in the 1950s, investigated the use of the antipsychotic medication chlorpromazine.[1][2] She discovered that the compound promazine had sedating properties despite not being an antihistamine like its precursor promethazine, and then extensively analyzed the properties of its descendant drug chlorpromazine.[3][4]

References

[edit]
  1. "Paul Charpentier, Henri-Marie Laborit, Simone Courvoisier, Jean Delay, and Pierre Deniker". Science History Institute. Retrieved 2024-11-09.
  2. Ban, Thomas A. (August 2007). "Fifty years chlorpromazine: a historical perspective". Neuropsychiatric Disease and Treatment. 3 (4): 495–500. PMC 2655089. PMID 19300578.
  3. Sneader, Walter (2002). "History of Drug Therapy. The 50th Anniversary of Chlorpromazine". Drug News & Perspectives. 15 (7): 466–471. doi:10.1358/dnp.2002.15.7.840082. PMID 12677184.
  4. Cookson, John (July 2019). "Histamine in psychiatry: promethazine as a sedative anticholinergic". BJPsych Advances. 25 (4): 265–268. doi:10.1192/bja.2019.21. ISSN 2056-4678.